Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases

Clinical trial NCT00098605 · COMPLETED

Trial details

NCT number: NCT00098605
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Central Nervous System Metastases HER2-positive Breast Cancer Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer Tumors Metastatic to Brain

Start date: 2004-10-01
Primary completion: 2006-09-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.